Assessment of dyspnea in acute decompensated heart failure: Insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow

Journal of the American College of Cardiology

Volumn 59, Issue 16, 2012, Pages 1441-1448

  Ezekowitz, Justin A ^a   Hernandez, Adrian F ^c   O'Connor, Christopher M ^c   Starling, Randall C ^d   Proulx, Guy ^b   Weiss, Mason H ^e   Bakal, Jeffrey A ^a   Califf, Robert M ^c   McMurray, John J V ^f   Armstrong, Paul W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e Centinela Freeman Regional Medical Center   (United States)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

heart failure; respiration; trials

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NESIRITIDE; NITRATE; OXYGEN; PLACEBO;

ACUTE HEART FAILURE; ADULT; AGE; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; BREATHING RATE; CARDIOVERSION; CONTROLLED STUDY; DRUG EFFICACY; DYSPNEA; DYSPNEA INDEX; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OXYGEN SATURATION; PEAK EXPIRATORY FLOW; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX RATIO; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSPNEA; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; PEAK EXPIRATORY FLOW RATE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84859568534     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.11.061     Document Type: Article

References (33)

1. A. Mebazaa, P.S. Pang, M. Tavares The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study Eur Heart J 31 2010 832 841
2. A.F. Hernandez, C.M. O'Connor, R.C. Starling Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF) Am Heart J 157 2009 271 277
3. P.S. Pang, J.G. Cleland, J.R. Teerlink A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach Eur Heart J 29 2008 816 824 (Pubitemid 351431028)
4. M. Gheorghiade, F. Follath, P. Ponikowski Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine Eur J Heart Fail 12 2010 423 433
5. C.M. O'Connor, R.C. Starling, A.F. Hernandez Effect of nesiritide in patients with acute decompensated heart failure N Engl J Med 365 2011 32 43
6. J.J. McMurray, J.R. Teerlink, G. Cotter Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials JAMA 298 2007 2009 2019 (Pubitemid 350074798)
7. J.R. Teerlink, M. Metra, G.M. Felker Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study Lancet 373 2009 1429 1439
8. Dyspnea Mechanisms, assessment, and management: a consensus statement Am J Respir Crit Care Med 159 1999 321 340
9. P.H. Quanjer, M.D. Lebowitz, I. Gregg, M.R. Miller, O.F. Pedersen Peak expiratory flow: conclusions and recommendations of a Working Party of the European Respiratory Society Eur Respir J Suppl 24 1997 2S 8S
10. H.K. Reddel, D.R. Taylor, E.D. Bateman An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice Am J Respir Crit Care Med 180 2009 59 99
11. R.K. Ailani, K. Ravakhah, B. DiGiovine Dyspnea differentiation index: a new method for the rapid separation of cardiac vs pulmonary dyspnea Chest 116 1999 1100 1104 (Pubitemid 29491884)
12. R.M. McNamara, D.J. Cionni Utility of the peak expiratory flow rate in the differentiation of acute dyspnea Cardiac vs pulmonary origin Chest 101 1992 129 132
13. O. Malas, B. Caglayan, A. Fidan, Z. Ocal, S. Ozdogan, E. Torun Cardiac or pulmonary dyspnea in patients admitted to the emergency department Respir Med 97 2003 1277 1281 (Pubitemid 37526994)
14. C.L. Emerman, R.K. Cydulka Use of peak expiratory flow rate in emergency department evaluation of acute exacerbation of chronic obstructive pulmonary disease Ann Emerg Med 27 1996 159 163 (Pubitemid 26055075)
15. D.J. Karras, M.E. Sammon, C.A. Terregino, B.L. Lopez, S.K. Griswold, G.K. Arnold Clinically meaningful changes in quantitative measures of asthma severity Acad Emerg Med 7 2000 327 334 (Pubitemid 30207971)
16. N.C. Santanello, J. Zhang, B. Seidenberg, T.F. Reiss, B.L. Barber What are minimal important changes for asthma measures in a clinical trial? Eur Respir J 14 1999 23 27 (Pubitemid 29411230)
17. R.E. Shiffler Maximum Z scores and outliers Am Stat 42 1988 79 80
18. R. Jaeschke, J. Singer, G.H. Guyatt Measurement of health status Ascertaining the minimal clinically important difference Control Clin Trials 10 1989 407 415 (Pubitemid 20025670)
19. S. Saint, S. Bent, E. Vittinghoff, D. Grady Antibiotics in chronic obstructive pulmonary disease exacerbations A meta-analysis JAMA 273 1995 957 960
20. W. Szafranski, A. Cukier, A. Ramirez Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease Eur Respir J 21 2003 74 81 (Pubitemid 36150304)
21. J. Vestbo, R. Pauwels, J.A. Anderson, P. Jones, P. Calverley Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease Thorax 60 2005 301 304 (Pubitemid 40522366)
22. M.J. Akerman, M. Yaegashi, Z. Khiangte, A.T. Murugan, O. Abe, J.D. Marmur Bronchodilator effect of infused B-type natriuretic peptide in asthma Chest 130 2006 66 72 (Pubitemid 44116842)
23. R.M. Angus, M.J. McCallum, N.C. Thomson Effect of inhaled atrial natriuretic peptide on methacholine induced bronchoconstriction in asthma Clin Exp Allergy 24 1994 784 788 (Pubitemid 24265179)
24. R.M. Angus, M.J. McCallum, G. Hulks, N.C. Thomson Bronchodilator, cardiovascular, and cyclic guanylyl monophosphate response to high-dose infused atrial natriuretic peptide in asthma Am Rev Respir Dis 147 1993 1122 1125 (Pubitemid 23149866)
25. L.A. Allen, A.F. Hernandez, C.M. O'Connor, G.M. Felker End points for clinical trials in acute heart failure syndromes J Am Coll Cardiol 53 2009 2248 2258
26. R.L. West, A.F. Hernandez, C.M. O'Connor, R.C. Starling, R.M. Califf A review of dyspnea in acute heart failure syndromes Am Heart J 160 2010 209 214
27. M. Metra, C.M. O'Connor, B.A. Davison Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study Eur Heart J 32 2011 1519 1534
28. A. Duguet, C. Tantucci, O. Lozinguez Expiratory flow limitation as a determinant of orthopnea in acute left heart failure J Am Coll Cardiol 35 2000 690 700 (Pubitemid 30167026)
29. L.A. Allen, M. Metra, O. Milo-Cotter Improvements in signs and symptoms during hospitalization for acute heart failure follow different patterns and depend on the measurement scales used: an international, prospective registry to evaluate the evolution of measures of disease severity in acute heart failure (MEASURE-AHF) J Card Fail 14 2008 777 784
30. K.K. Iversen, J. Kjaergaard, D. Akkan The prognostic importance of lung function in patients admitted with heart failure Eur J Heart Fail 12 2010 685 691
31. C. Pison, J.L. Malo, J.L. Rouleau, J. Chalaoui, H. Ghezzo, J. Malo Bronchial hyperresponsiveness to inhaled methacholine in subjects with chronic left heart failure at a time of exacerbation and after increasing diuretic therapy Chest 96 1989 230 235 (Pubitemid 19199526)
32. A.N. Aggarwal, D. Gupta, S.K. Jindal The relationship between FEV1 and peak expiratory flow in patients with airways obstruction is poor Chest 130 2006 1454 1461 (Pubitemid 44786740)
33. S.A. Evans, W.J. Kinnear, L. Watson, M. Hawkins, A.J. Cowley, I.D. Johnston Breathlessness and exercise capacity in heart failure: the role of bronchial obstruction and responsiveness Int J Cardiol 57 1996 233 240 (Pubitemid 27037391)